{"id":2060,"date":"2024-11-25T15:27:00","date_gmt":"2024-11-25T20:27:00","guid":{"rendered":"https:\/\/research.ncsu.edu\/win\/?p=2060"},"modified":"2025-02-24T15:29:55","modified_gmt":"2025-02-24T20:29:55","slug":"win-and-harbright-invest-over-500k-in-lumata-to-save-eyesight","status":"publish","type":"post","link":"https:\/\/research.ncsu.edu\/win\/win-and-harbright-invest-over-500k-in-lumata-to-save-eyesight\/","title":{"rendered":"WIN and Harbright Invest Over $500K in Lumata to Save Eyesight"},"content":{"rendered":"\n\n\n\n\n
FOR IMMEDIATE RELEASE<\/strong><\/p>\n\n\n\n Raleigh,<\/strong> NC\u2014November 25th,<\/strong> 2024 \u2014<\/strong>The Wolfpack<\/strong> Investor<\/strong> Network<\/strong><\/a> (WIN)<\/strong> and Harbright<\/strong> Ventures<\/strong><\/a> are thrilled to announce an additional investment in Lumata<\/strong> Health,<\/strong> Inc<\/strong><\/a>. (Lumata), bringing their total investment to over half a million dollars. Lumata operates an ophthalmology care management platform dedicated to preventing blindness and supporting patients with chronic eye conditions.<\/p>\n\n\n\n According to the Centers for Disease Control and Prevention<\/strong><\/a>, vision and eye problems are increasing as the US population ages, affecting over 90M Americans aged 40 and older \u2014 60% of the over-40 population.<\/p>\n\n\n\n Without effective interventions by 2050:<\/strong><\/p>\n\n\n\n Lumata\u2019s human-led, intelligent eye care management platform addresses the critical challenge of preventing vision loss from chronic eye conditions like glaucoma, diabetic retinopathy, macular degeneration, and dry eye. Acting as a remote extension of in-clinic staff, the platform identifies and removes complex barriers to treatment adherence, enabling patients to maintain eye health. While these conditions cause irreversible damage, Lumata helps slow disease progression in 95% of cases through effective monitoring and treatments<\/strong><\/a>, including injections, surgery, laser therapy, eye drops, and oral medications \u2014 ultimately reducing the risk of blindness.<\/p>\n\n\n\n NC State Mechanical and Aerospace Engineering professor Landon Grace<\/strong><\/a> is currently on sabbatical to focus on Lumata\u2019s growth as its CEO. His leadership at Lumata and academic expertise reflect NC State<\/strong><\/a>\u2019s<\/strong> commitment to driving innovative solutions.<\/p>\n\n\n\n \u201cThe investment from WIN and Harbright enables us to expand our reach and accelerate our mission to prevent vision loss on a national scale,” said Landon Grace, CEO of Lumata. “We are committed to leveraging cutting-edge technology and data science to deliver the highest level of care coordination, and with WIN\u2019s support, we\u2019re one step closer to eliminating preventable blindness.\u201d<\/p>\n\n\n\n Founded in 2017, Lumata has rapidly enrolled thousands of patients and operates in 33 states, up from 6 in 2022. The company is also piloting and expanding its services with some of the nation\u2019s largest multicenter eye care practices, covering more than 600 locations and 1K physicians. Clinics using Lumata Health\u2019s platform and care support services have achieved a remarkable 60% reduction in delayed appointments. Recently, Lumata secured a 30-month agreement with one of the world\u2019s largest pharmaceutical companies.<\/p>\n\n\n\n \u201cWe are proud to support Lumata in their mission to combat preventable blindness,\u201d said John Leachman, partner at Harbright Ventures. \u201cLandon Grace\u2019s leadership and the company\u2019s innovative approach to care coordination represent the future of healthcare, and we\u2019re excited to be part of their journey.\u201d<\/p>\n\n\n\n This investment underscores WIN\u2019s commitment to high-impact startups tied to NC State. WIN is excited to support Lumata as it transforms chronic eye disease management.<\/p>\n","protected":false},"excerpt":{"rendered":" The Wolfpack Investor Network (WIN) and Harbright Ventures are thrilled to announce an additional investment in Lumata Health, Inc. (Lumata), bringing their total investment to over half a million dollars. Lumata operates an ophthalmology care management platform dedicated to preventing blindness and supporting patients with chronic eye conditions.<\/p>\n","protected":false},"author":239,"featured_media":2062,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ncst_custom_author":"","ncst_show_custom_author":false,"ncst_dynamicHeaderBlockName":"ncst\/default-post-header","ncst_dynamicHeaderData":"{\"showAuthor\":false,\"showDate\":true,\"showFeaturedVideo\":false,\"showReadingTime\":false}","ncst_content_audit_freq":"","ncst_content_audit_date":"","ncst_content_audit_display":false,"ncst_backToTopFlag":"","footnotes":""},"categories":[9,189],"tags":[56,175,237,228,235,182,156,178,59,35,47],"class_list":["post-2060","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-press-releases","tag-angel-investing","tag-biospatial","tag-cdc","tag-emergency-medical-services","tag-eyesight","tag-harbright-ventures","tag-healthcare","tag-nc-state-entrepreneurship","tag-north-carolina-startups","tag-vision","tag-wolfpack-investor-network"],"displayCategory":null,"acf":{"ncst_posts_meta_modified_date":""},"yoast_head":"\n\n